Loading
Latest filing published 28 Aug 2026 for Attovia Therapeutics, Inc., €1.9M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 28 August 2026, Goldman Sachs Group Inc disclosed a transaction of €1.9M in Attovia Therapeutics, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration